р на фондапаринукс 2, 5 mg веднъж дневно спрямо обичайна терапия (плацебо (47%) или
In the subgroup of patients treated with fondaparinux or enoxaparin who underwent PCI, 8.8% and 8.2% of patients respectively, experience death/ MI/ RI within 9 days of randomisation (hazard ratio M